Since nuclear AR and mTOR transcriptionally activate hundreds of genes in AA PCa and CRPC, miR-99b-5p potentially functions as an epigenomic driver mediating the AA PCa aggressiveness and drug resistance. The gene discussed is AR; the disease is posterior cortical atrophy.